Sunday, November 7, 2021

FDA makes it very difficult to identify the temporary members who voted at its recent VRBPAC meeting on 5-11 year old COVID vaccines. I want to make it easier for others to correctly identify their conflicts of interest

Below are the permanent members of the committee--but most were not at the meeting, which was stuffed with 11 temporary members whose votes were assured, plus 7 or 8 of the permanent members.

I have put a line through those who did not attend, and added the temporary members who replaced them at the bottom of the page.


Hana El Sahly, M.D.
Expertise: Vaccines, Infectious Diseases
Term: 06/21/2019-01/31/2022
Department of Molecular Virology and Microbiology
Department of Medicine
Section of Infectious Diseases
Baylor College of Medicine
Houston, TX 77030

Paula Annunziato, M.D. ***
Expertise: Industry Representative
Term: 02/01/2020-01/31/2024
Vice President and Therapeutic Area Head
Vaccines Clinical Research
North Wales, PA 19454

Archana Chatterjee, M.D., Ph.D.
Expertise: Pediatrics, Infectious Diseases
Term: 06/21/2019-01/31/2023
Dean Chicago Medical School
Vice President for Medical Affairs
Rosalind Franklin University of Medicine and Science
North Chicago, IL 60064

CAPT Amanda Cohn, M.D.
Expertise: Pediatrics, Vaccines
Term: 02/01/2020-01/31/2024
Chief Medical Officer
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention
Atlanta, GA 30333

Hayley Gans, M.D.
Expertise: Pediatrics, Infectious Diseases
Term: 06/21/2019-01/31/2023
Professor of Pediatrics
Department of Pediatrics
Stanford University Medical Center
Stanford, CA 94305

Holly Janes, Ph.D.
Expertise: Biostatistics
Term: 02/01/2020-01/31/2023
Fred Hutchinson Cancer Research Center
Vaccine and Infectious Disease Division
Division of Public Health Sciences
Seattle, WA 98109

Michael Kurilla, M.D., Ph.D.
Expertise: Infectious Diseases, Pathology
Term: 08/06/2018-01/31/2022
Director, Division of Clinical Innovation
National Center for Advancing Translation Sciences
National Institutes of Health
Bethesda, MD 20852

Myron Levine, M.D., D.T.P.H., F.A.A.P
Expertise: Infectious Diseases
Term: 05/09/2018-01/31/2022
Simon & Bessie Grollman Distinguished Professor
Associate Dean for Global Health
Vaccinology and Infectious Diseases
Center for Vaccine Development
University of Maryland School of Medicine
Baltimore, MD 21201

H. Cody Meissner, M.D.
Expertise: Infectious Diseases
Term: 08/06/2018-01/31/2022
Professor of Pediatrics
Tufts University School of Medicine
Director, Pediatric Infectious Disease
Tufts Medical Center
Boston, MA 02111

Paul Offit, M.D.
Expertise: Infectious Diseases
Term: 02/01/2018-01/31/2022
Professor of Pediatrics
Division of Infectious Diseases
Abramson Research Building
The Children’s Hospital of Philadelphia
Philadelphia, PA 19104

Steven Pergam, M.D.
Expertise: Infectious Diseases
Term: 02/01/2020-01/31/2024
Medical Director
Infection Prevention
Seattle Cancer Care Alliance
Seattle, WA 98109

Andrea Shane, M.D., M.P.H., M.Sc.
Expertise: Pediatric & Infectious Diseases
Term: 02/01/2018-01/31/2022
Professor of Pediatrics
Division of Pediatric Infectious Diseases
Emory University School of Medicine
Atlanta, GA 30322

Paul Spearman, M.D.
Expertise: Pediatric & Infectious Diseases
Term: 05/09/2018-01/31/2022
Director, Division of Infectious Diseases
Albert B. Sabin Chair in Pediatric Infectious Diseases
Cincinnati Children’s Hospital
Medical Center
Professor, Department of Pediatrics
University of Cincinnati School of Medicine
Cincinnati, OH 45229

Geeta K. Swamy, M.D.
Expertise: Infectious Diseases
Term: 08/06/2018-01/31/2022
Senior Associate Dean
Vice Chair for Research & Faculty Development
Associate Professor, ObGyn
Department of Obstetrics & Gynecology
Division of Maternal-Fetal Medicine
Duke University
Durham, NC 27710

Gregg Sylvester, M.D., M.P.H. +
Expertise: Alternate Industry Representative
Term: 02/01/2020-01/31/2024
Vice President
Medical Affairs
Seqirus Inc.
Summit, NJ 07901


Fuller, A. Oveta, Ph.D. African Studies Center International Institute Associate Professor of Microbiology and Immunology, Medical School University of Michigan Ann Arbor, MI 48109 

Hildreth, Sr., James, Ph.D., M.D. Professor Department of Internal Medicine School of Medicine President and Chief Executive Officer Meharry Medical College Nashville, TN 37205 

Lee, Jeannette, Ph.D. Professor Department of Biostatistics University of Arkansas for Medical Sciences Little Rock, AR 72701 

Levy, Ofer, M.D., Ph.D. Staff Physician & Principal Investigator Director, Precision Vaccines Program Division of Infectious Diseases Boston Children’s Hospital Professor, Harvard Medical School Associate Member Broad Institute Massachusetts Institute of Technology Cambridge, MA 02140 

Moore, Patrick, M.D., M.P.H. Distinguished and American Cancer Society Professor Pittsburgh Foundation Chair in Innovative Cancer Research University of Pittsburgh Cancer Institute Pittsburgh, PA 15213  

Nelson, Michael, M.D., Ph.D. Sawyer, Mark, M.D., F.A.A.P. Professor of Medicine Professor of Clinical Pediatrics Chief Division of Infectious Diseases Asthma, Allergy and Immunology Division Vice Chair for Education UVA Health & UVA School of Medicine Department of Pediatrics Charlottesville, VA 22904 

Sawyer, Mark, M.D., F.A.A.P. Professor of Medicine Professor, University of California San Diego School of Medicine, Departments of Microbiology and Immunology, Rady Children’s Hospital San Diego La Jolla, CA 92093 

Perlman, Stanley, M.D., Ph.D. University of Iowa Associate Director for Vaccine Policy Iowa City, IA 52242 National Center for Immunization and Respiratory Diseases 
Professor of Pediatrics Mark Stinksi Chair in Virology 

Wharton, Melinda, M.D., MPH University of Iowa Associate Director for Vaccine Policy Iowa City, IA 52242 National Center for Immunization and Respiratory Diseases 

Portnoy, Jay, M.D. **  Acting Consumer Representative Atlanta, GA 30333 Professor of Pediatrics Medical Director of Telemedicine Section of Allergy, Asthma and Immunology Children's Mercy Hospital Kansas City, MO 64108 

Rubin, Eric, M.D., Ph.D. Editor-in-Chief New England Journal of Medicine Adjunct Professor Department of Immunology and Harvard TH Chan School of Public Health Associate Physician Brigham and Women’s Hospital Boston, MA 02115


Anonymous said...

'FDA Documents Show CV19 Vax Produces a Bioweapon' – Karen Kingston.

Anonymous said...


Anonymous said...

Happy couples: How to keep your relationship healthy
Keep your romantic partnership in good working order by talking openly, keeping it interesting and seeking help if needed.

Nov 04, 2021 · Divorce rate rises amid ‘massive pressure’ from COVID-19 lockdowns.

COVID-19 crisis has increased Americans already record high divorce rates higher across America

US Divorce Rates Soar During COVID-19 Crisis
Up A Third

COVID-19 lockdown ended there in March. In the U.S., sales of online self-help divorce agreements rose by 34% this spring compared to last year, and family lawyers surveyed a 25% to 35% increase in requests to start divorce proceedings

Divorce rates up 30% due to COVID-19 pandemic

Divorce Filings Have Skyrocketed’: Lawyer On Impact Of COVID-19 On Marriages

The last data and statistics I’ve seen said there’s been a 30% increase in divorce filings post-quarantine and that definitely sounds about right,” said Thomas. “We have been bombarded. We meaning divorce practitioners. This was just the straw that broke the camel’s back. The courts are backlogged and unless you have some urgent, emergency situation, you should expect to wait to get your case back on the docket. All the cases from March-June that were cancelled have to be rescheduled. You should expect to wait, which is why I encourage people to settle the legal issues they have. If you do get to court, it’s so weird doing these trials by Zoom on child custody and alimony.”

The California divorce rate is now at a staggering 75 percent. Three out of four marriages in the Golden State end in divorce

Divorces Marriages
161,905 194,108 83.41% California Divorce Rate

Average Divorce Rate: 75.54%**

Bowling Green State University named this phenomenon the “gray divorce revolution.” Their study found the divorce rate for the U.S. population over 50 doubled in those two decades and more than doubled for those over 65. Since half of the married population is 50 and over, these researchers projected that, as the U.S. population ages, by 2030, the number of persons aged 50 and older who divorce will grow by one-third.

85% of the couples that commit to cohabitation will either break-up or divorce by the end of 10 years.

Lasts 8 yrs on average